Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Meis

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Antimicrobial Agents and Chemotherapy|December 9, 2015
International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution MethodA Espinel-Ingroff, A L Colombo, S Cordoba, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2018
Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in GermanyR Seufert, L Sedlacek, B Kahl, et al.
Persoonia|January 30, 2016
Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reportsY Zhang, F Hagen, B Stielow, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosineA Espinel-Ingroff, A Chowdhary, M Cuenca-Estrella, et al.
Persoonia|September 13, 2013
Taxonomy and epidemiology of Mucor irregularis, agent of chronic cutaneous mucormycosisX-L Lu, M J Najafzadeh, S Dolatabadi, et al.
Antimicrobial Agents and Chemotherapy|September 11, 2013
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?A Espinel-Ingroff, M C Arendrup, M A Pfaller, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 3, 2011
European expert opinion on the management of invasive candidiasis in adultsB J Kullberg, P E Verweij, M Akova, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazoleA Espinel-Ingroff, A I Aller, E Canton, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2014
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013O A Cornely, S Arikan-Akdagli, E Dannaoui, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2014
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and othersA M Tortorano, M Richardson, E Roilides, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Antimicrobial Agents and Chemotherapy|December 9, 2015
International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution MethodA Espinel-Ingroff, A L Colombo, S Cordoba, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2018
Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in GermanyR Seufert, L Sedlacek, B Kahl, et al.
Persoonia|January 30, 2016
Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reportsY Zhang, F Hagen, B Stielow, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosineA Espinel-Ingroff, A Chowdhary, M Cuenca-Estrella, et al.
Persoonia|September 13, 2013
Taxonomy and epidemiology of Mucor irregularis, agent of chronic cutaneous mucormycosisX-L Lu, M J Najafzadeh, S Dolatabadi, et al.
Antimicrobial Agents and Chemotherapy|September 11, 2013
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?A Espinel-Ingroff, M C Arendrup, M A Pfaller, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 3, 2011
European expert opinion on the management of invasive candidiasis in adultsB J Kullberg, P E Verweij, M Akova, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazoleA Espinel-Ingroff, A I Aller, E Canton, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2014
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013O A Cornely, S Arikan-Akdagli, E Dannaoui, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2014
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and othersA M Tortorano, M Richardson, E Roilides, et al.
Pageof 27